Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents

Bibliographic Details
Title: Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents
Authors: Viviana Poliseno, Sílvia Chaves, Leonardo Brunetti, Fulvio Loiodice, Antonio Carrieri, Antonio Laghezza, Paolo Tortorella, João D. Magalhães, Sandra M. Cardoso, M. Amélia Santos, Luca Piemontese
Source: Biomolecules, Vol 11, Iss 1, p 111 (2021)
Publisher Information: MDPI AG, 2021.
Publication Year: 2021
Collection: LCC:Microbiology
Subject Terms: Alzheimer’s disease, tenuazonic acid, donepezil, neurodegenerative, metal chelation, multifunctional drugs, Microbiology, QR1-502
More Details: Alzheimer’s disease (AD) is generally recognized as a multifactorial neurodegenerative pathology with an increasing impact on society. Tenuazonic acid (TA) is a natural compound that was recently identified as a potential multitarget ligand with anti-cholinesterase, anti-amyloidogenic and antioxidant activities. Using its structure as a chemical scaffold, we synthesized and evaluated new derivatives (1–5), including tenuazonic-donepezil (TA-DNP) hybrids (4 and 5) due to the clinical importance of the anti-AD drug donepezil. These novel compounds all achieved activity in the micromolar range towards all selected targets and demonstrated to be potentially orally absorbed. Moreover, a selected compound (1) was further investigated as a chelating agent towards copper (II), zinc (II) and iron (III) and showed good chelating ability (pFe = 16.6, pCu = 11.6, pZn = 6.0 at pH 7.4). Therefore, the TA motif can be considered an interesting building block in the search for innovative multi-functional anti-neurodegenerative drugs, as exemplified by hybrid 5, a promising non-cytotoxic lead compound adequate for the early stages of AD, and capable of ameliorating the oxidative status of SH-SY5Y human neuroblastoma cells.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2218-273X
Relation: https://www.mdpi.com/2218-273X/11/1/111; https://doaj.org/toc/2218-273X
DOI: 10.3390/biom11010111
Access URL: https://doaj.org/article/a3c4a1415d71427290b1e8bfee5412bc
Accession Number: edsdoj.3c4a1415d71427290b1e8bfee5412bc
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:2218273X
DOI:10.3390/biom11010111
Published in:Biomolecules
Language:English